ADVFN
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,280.46
      0.27%
      US Tech 100
      22,245.20
      -0.02%
      Dow Jones
      44,650.64
      0.43%
      Brent Oil
      68.285
      -0.20%
      Bitcoin
      116,970.00
      0.83%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      1. Home
      2. Investing
      3. Stocks
      4. Australia
      5. ASX

      6. Next Science Limited (NXS) Quote

      Next Science Limited

      Next Science Limited (NXS)

      Nexans
      Nexus Gold Corp
      0.14
      0.0025
      ( 1.82% )
      Updated: 23:33:14
      20 min delayed - Upgrade to Realtime

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      0.14
      ( 1.82% )
      Bid
      0.135
      Ask
      0.14
      Volume
      67,259
      0.135 Day's Range 0.14
      0.056 52 Week Range 0.305
      Market Cap
      40.837M
      Previous Close
      0.1375
      Open
      0.135
      Last Trade
      245
      @
      0.14
      Last Trade Time
      23:33:14
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      435,801
      Shares Outstanding
      291,695,103
      Dividend Yield
      -
      PE Ratio
      -3.86
      Earnings Per Share (EPS)
      -0.04
      Revenue
      22.92M
      Net Profit
      -10.59M

      About Next Science Limited

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.nextscience.com/
      Headquarters
      Sydney, New South Wales, Aus
      Founded
      -
      Next Science Limited is listed in the Biological Pds,ex Diagnstics sector of the Australian Stock Exchange with ticker NXS. The last closing price for Next Science was AUD0.14. Over the last year, Next Science shares have traded in a share price range of AUD 0.056 to AUD 0.305.

      Next Science currently has 291,695,103 shares outstanding. The market capitalization of Next Science is AUD40.11 million. Next Science has a price to earnings ratio (PE ratio) of -3.86.

      Ask ADVFN Intelligence (AI)

      NXS Latest News

      More News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.0053.70370370370.1350.140.137893810.13677525DE
      40.073108.9552238810.0670.150.05610625570.11268059DE
      120.04141.41414141410.0990.150.0564358010.10727097DE
      260.0327.27272727270.110.150.0563073710.10958025DE
      52-0.07-33.33333333330.210.3050.0562419880.13216425DE
      156-0.69-83.13253012050.831.080.0561740540.29008865DE
      260-1.33-90.47619047621.472.060.0561645170.66159455DE

      NXS - Frequently Asked Questions (FAQ)

      What is the current Next Science share price?
      The current share price of Next Science is AUD 0.14
      How many Next Science shares are in issue?
      Next Science has 291,695,103 shares in issue
      What is the market cap of Next Science?
      The market capitalisation of Next Science is AUD 40.11M
      What is the 1 year trading range for Next Science share price?
      Next Science has traded in the range of AUD 0.056 to AUD 0.305 during the past year
      What is the PE ratio of Next Science?
      The price to earnings ratio of Next Science is -3.86
      What is the cash to sales ratio of Next Science?
      The cash to sales ratio of Next Science is 1.78
      What is the reporting currency for Next Science?
      Next Science reports financial results in USD
      What is the latest annual turnover for Next Science?
      The latest annual turnover of Next Science is USD 22.92M
      What is the latest annual profit for Next Science?
      The latest annual profit of Next Science is USD -10.59M
      What is the registered address of Next Science?
      The registered address for Next Science is LEVEL 14, AUSTRALIA SQUARE, 264-278 GEORGE STREET, SYDNEY, NEW SOUTH WALES, 2000
      What is the Next Science website address?
      The website address for Next Science is www.nextscience.com/
      Which industry sector does Next Science operate in?
      Next Science operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      IMUImugene Limited
      AUD 0.405
      (2,792.86%)
      		168.96k
      IMUOEImugene Ltd
      AUD 0.005
      (400.00%)
      		3.86M
      SUMOSummit Minerals Ltd
      AUD 0.004
      (100.00%)
      		707.51k
      BPHOCommon Stock
      AUD 0.002
      (100.00%)
      		4.36M
      TD1Tali Digital Limited
      AUD 0.002
      (100.00%)
      		5.44M
      ICUInvestor Centre Ltd
      AUD 0.001
      (-66.67%)
      		752.31k
      UNTOAUnith Ltd
      AUD 0.001
      (-66.67%)
      		278k
      M2ROAMiramar Resources Limited
      AUD 0.001
      (-50.00%)
      		3.5M
      HLXHelix Resources Limited
      AUD 0.001
      (-50.00%)
      		4.01M
      ADXOADX Energy Limited
      AUD 0.001
      (-50.00%)
      		440k
      ATHAlterity Therapeutics Ltd
      AUD 0.013
      (44.44%)
      		69.98M
      SYASayona Mining Limited
      AUD 0.0185
      (8.82%)
      		49.08M
      DTRDateline resources Ltd
      AUD 0.098
      (9.50%)
      		46.61M
      LKYLocksley Resources Ltd
      AUD 0.088
      (27.54%)
      		42.34M
      AUZAustralian Mines Limited
      AUD 0.007
      (0.00%)
      		39.58M

      Discussion

      View Full Feed
      DTGoody DTGoody 9 minutes ago
      I asked the same question but left out the "Q" on the end of the ticker and got a different answer from Bing Chat. This answer leaves some hope for us:

      Possibility of Relisting HGEN After Bankruptcy
      Current Status of the HGEN Ticker
      Humanigen’s common shares trade under
      Acme Investments Acme Investments 10 minutes ago
      Those guys got a call at the end of 2020 and I'm not going to speculate about from who!! He said let them all run and Viola!! It's going to happen again, maybe not as big but don't blink!!
      RDAR
      Gernee20 Gernee20 11 minutes ago
      FOMO has definitely prevented me from making money over the last 10 years. FOMO, and greed
      AVXL
      HomeRunSwing HomeRunSwing 14 minutes ago
      Next time here?
      ASST
      tschussmann1 tschussmann1 16 minutes ago
      Thinking of what the short strategy might be given the likelyhood of approval for Alzheimer’s. According to an AI search, only 29% of CNS candidate drugs move from phase 2 to phase 3, so just based on history, an attack on bad news there would be expected. Of course Ananex is changing history, so
      AVXL
      s404n1tn0cc s404n1tn0cc 17 minutes ago
      Ain't that the case. HAHAHH
      Hey Goodietime have him try and save
      me. Say... didn't he say he was going else where??
      Two months ago..HEHEHE
      LEHNQ
      grubstake grubstake 19 minutes ago
      Extra buying op? Was expecting $1.00+ let’s go, til they crushed it at 3:30 today. Need $1 for Nasd. Compliance. May have to dig up $ for some more shares
      ICU
      reaper247 reaper247 21 minutes ago
      Hey surfkast, isnt this the GVSI board?

      Looks like almost $800,000 in fees for four empty shells in 2024.

      When it comes to GVSI, none of those administrative fees are going into Sharp's pocket to support his racing hobby.

      None. Period.

      You
      GVSI
      hotmeat hotmeat 21 minutes ago
      A "year ago" Vivos didn't possess human clinical data to bolster their IDE application.
      RDGL
      BDEZ BDEZ 22 minutes ago
      BTC now on crack...
      BTCUSD
      Gus1212 Gus1212 23 minutes ago
      But there will BE a global expansion.

      One step at a time!

      Don't be short-sighted
      NWBO
      hotmeat hotmeat 25 minutes ago
      All we await is Vivos formally announcing that the IDE has been submitted so there's no reason it cant be Pr'd at any point today.

      I don't see how Tuesday would be possible because that would mean they missed their own official deadline for submission, ie July 14th.
      RDGL
      DTGoody DTGoody 26 minutes ago
      This is from Bing chat and it does not look good for us shareholders: Is Restoration Possible?
      In theory, any cancelled share can be “recreated” by corporate action—but in practice, HGENQ holders cannot simply reactivate their old positions. Restoring cancelled shares requires the company to:
      littlejohn littlejohn 28 minutes ago
      Trump really appears mentally unstable Dude,

      https://www.cnbc.com/2025/07/11/trump-announces-35percent-tariffs-on-canada-starting-aug-1.html

      Or with the market past high priced, is

      it another setup for big Jew shorts?,

      He tucked tail and fl
      SOFI
      joyceschoice joyceschoice 35 minutes ago
      There's a new youtube on Lehman's bankruptcy. It's a good history and the end is what it is.

      https://www.youtube.com/watch?v=7rKeXl9VJXI.

      It is worth watching to end. The british accent is probably a red herring or a cheshire cat imo.

      One more thin
      LEHNQ
      konshe konshe 36 minutes ago
      Questions:
      1, O/S shares reduced 335,000,000 shares from 6/20/25 48512382190 to 6/27/25 4,516,382,190, Why? Means no dilution
      2, Today who are sold 98,965,225 shares? Is it dilution again?
      AFFU
      SDCRBS SDCRBS 40 minutes ago
      Eagle1, my MHO is in full agreement with yours ...

      Melvin is an Outstanding CEO and Melvin has made known what his plans are for VeeMost. Just look at he has accomplished and is planning to accomplish:

      "As CEO and President of VeeMost Technologies Inc. (OTC: VMST), I l
      VMST
      JMCK6193 JMCK6193 45 minutes ago
      Hey capt, what happened to rolls in the AH? Down .37 
      NXPL
      na na na na 46 minutes ago
      Thank you
      GTCH
      Slave1 Slave1 46 minutes ago
      Just to clarify for anyone reading, the method licensed by NWBO from Roswell isn’t just about using dendritic cells with lysate. It’s specifically designed to activate T cells that can recognize not only tumor cells but also the blood vessels and support structures feeding the tumor. That vascular t
      NWBO
      3331 3331 47 minutes ago
      ActiPatch/RecoveryRx + Smartphone = $$$
      Making ActiPatch/RecoveryRx work with just a smartphone, instead of fancy smartwatches, saves hug money by using something everyone already has – a smartphone! How it works:
      Your Smartphone: The Brains of the Operation
      Think of your smart
      GPS
      JimmyRich JimmyRich 48 minutes ago
      I know and I don’t know if saying that this could have been handled a lot better is completely accurate… but I think we all think things could have and should have been done a lot better.. cleaner and more efficiently… nonetheless… it actually does take around 6-7 Years to get the approval that we a
      UEEC

      Your Recent History

      ASX
      NXS
      Next Science
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads